Here are three recent updates on Teplizumab. You can read my previous summary of this drug here:https://cureresearch4type1diabetes.blogspot.com/2019/09/teplizumab-phase-ii-results-for.htmland all my Teplizumab postings here:https://cureresearch4type1diabetes.blogspot.com/search/label/Teplizumab
Updates from ADA 2020
- Will repeated dosing of Teplizumab continue to delay the onset of T1D?
- Will dosing of Teplizumab in people with established T1D lead to increased insulin production, and therefore make their T1D easier to treat? This study shows that increase for people who are at-risk of T1D, but we don't know about people who already have T1D.
- Is there are some way to know ahead of time what sort of at-risk people will be helped by this treatment, and which will not?